RIVM launches study on long-term effectiveness of COVID-19 vaccines RIVM is launching an extensive study today to research the long-term effectiveness of the various COVID-19 vaccines in the Netherlands.
How to distinguish a dual user from an exclusive e-cigarette user RIVM and Maastricht University have identified a combination of factors that can be used to distinguish between exclusive e-cigarette users (vapers) on the one hand and people who smoke both regula
Thematic report Public Health Status and Forecast 2014 The number of chronically ill people in the Netherlands has been increasing.